Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
3.250
+0.280 (9.43%)
Nov 22, 2024, 4:00 PM EST - Market closed
Fulcrum Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 175 | 417 | 379 | 717 | 319 | 375 | |
| Market Cap Growth | -18.84% | 10.13% | -47.15% | 124.42% | -14.89% | - | |
| Enterprise Value | -73 | 172 | 171 | 477 | 192 | 274 | |
| Last Close Price | 3.25 | 6.75 | 7.28 | 17.69 | 11.71 | 16.64 | |
| PS Ratio | 2.50 | 148.77 | 59.75 | 37.41 | 36.21 | - | |
| PB Ratio | 0.68 | 1.77 | 1.90 | 3.39 | 3.36 | 4.31 | |
| P/TBV Ratio | 0.87 | 1.77 | 1.90 | 3.39 | 3.36 | 4.31 | |
| EV/Sales Ratio | - | 61.21 | 26.99 | 24.87 | 21.81 | - | |
| Debt / Equity Ratio | 0.04 | 0.05 | 0.07 | - | 0.00 | 0.00 | |
| Asset Turnover | 0.29 | 0.01 | 0.03 | 0.11 | 0.07 | - | |
| Quick Ratio | 18.09 | 17.44 | 12.20 | 11.58 | 4.33 | 7.98 | |
| Current Ratio | 18.44 | 17.71 | 12.41 | 11.77 | 4.47 | 8.24 | |
| Return on Equity (ROE) | -6.99% | -44.84% | -53.53% | -52.72% | -77.68% | -101.35% | |
| Return on Assets (ROA) | -6.36% | -28.56% | -30.36% | -27.79% | -37.29% | -53.65% | |
| Return on Capital (ROIC) | -6.65% | -30.18% | -33.07% | -33.03% | -49.08% | -64.48% | |
| Earnings Yield | -10.22% | -23.32% | -28.99% | -11.28% | -22.17% | -22.03% | |
| FCF Yield | -4.99% | -21.92% | -26.13% | -11.18% | -17.22% | -10.77% | |
| Buyback Yield / Dilution | -5.50% | -36.27% | -27.23% | -39.47% | -129.53% | -778.76% | |
| Total Shareholder Return | -5.50% | -36.27% | -27.23% | -39.47% | -129.53% | -778.76% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.